ARIH1 and neoplasm: Xenograft injection of two ARIH1 shRNA clones into the mammary fat pad of NOD-SCID mice resulted in no tumors observed at 7 weeks, at which point mice injected with scrambled control cells had reached a maximum tumor burden of 2000 mm3 (Fig. 5a, b, Supplementary Fig. S3e).